Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil + propofol for painless gastroscopy
ChiCTR2100052992Phase 4Recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Nov 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil and propofol in gastrointestinal conditions and None (5 arms), sponsored by Xuzhou Central Hospital. Primary endpoint: Effective sedation during diagnosis and treatment. Started Nov 2021; status: recruiting.
02
Drugs
remifentanilpropofol
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2100052992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052992.